Global IgA Nephropathy Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global IgA Nephropathy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Phase I
  • 1.2.3 Phase II
  • 1.2.4 Phase III
• 1.3 Market by Application
  • 1.3.1 Global IgA Nephropathy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Clinical Treatment
  • 1.3.3 Drug Experiment
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global IgA Nephropathy Drugs Market Perspective (2017-2028)
• 2.2 IgA Nephropathy Drugs Growth Trends by Region
  • 2.2.1 IgA Nephropathy Drugs Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 IgA Nephropathy Drugs Historic Market Size by Region (2017-2022)
  • 2.2.3 IgA Nephropathy Drugs Forecasted Market Size by Region (2023-2028)
• 2.3 IgA Nephropathy Drugs Market Dynamics
  • 2.3.1 IgA Nephropathy Drugs Industry Trends
  • 2.3.2 IgA Nephropathy Drugs Market Drivers
  • 2.3.3 IgA Nephropathy Drugs Market Challenges
  • 2.3.4 IgA Nephropathy Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top IgA Nephropathy Drugs Players by Revenue
  • 3.1.1 Global Top IgA Nephropathy Drugs Players by Revenue (2017-2022)
  • 3.1.2 Global IgA Nephropathy Drugs Revenue Market Share by Players (2017-2022)
• 3.2 Global IgA Nephropathy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by IgA Nephropathy Drugs Revenue
• 3.4 Global IgA Nephropathy Drugs Market Concentration Ratio
  • 3.4.1 Global IgA Nephropathy Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by IgA Nephropathy Drugs Revenue in 2021
• 3.5 IgA Nephropathy Drugs Key Players Head office and Area Served
• 3.6 Key Players IgA Nephropathy Drugs Product Solution and Service
• 3.7 Date of Enter into IgA Nephropathy Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 IgA Nephropathy Drugs Breakdown Data by Type

• 4.1 Global IgA Nephropathy Drugs Historic Market Size by Type (2017-2022)
• 4.2 Global IgA Nephropathy Drugs Forecasted Market Size by Type (2023-2028)

5 IgA Nephropathy Drugs Breakdown Data by Application

• 5.1 Global IgA Nephropathy Drugs Historic Market Size by Application (2017-2022)
• 5.2 Global IgA Nephropathy Drugs Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America IgA Nephropathy Drugs Market Size (2017-2028)
• 6.2 North America IgA Nephropathy Drugs Market Size by Type
  • 6.2.1 North America IgA Nephropathy Drugs Market Size by Type (2017-2022)
  • 6.2.2 North America IgA Nephropathy Drugs Market Size by Type (2023-2028)
  • 6.2.3 North America IgA Nephropathy Drugs Market Share by Type (2017-2028)
• 6.3 North America IgA Nephropathy Drugs Market Size by Application
  • 6.3.1 North America IgA Nephropathy Drugs Market Size by Application (2017-2022)
  • 6.3.2 North America IgA Nephropathy Drugs Market Size by Application (2023-2028)
  • 6.3.3 North America IgA Nephropathy Drugs Market Share by Application (2017-2028)
• 6.4 North America IgA Nephropathy Drugs Market Size by Country
  • 6.4.1 North America IgA Nephropathy Drugs Market Size by Country (2017-2022)
  • 6.4.2 North America IgA Nephropathy Drugs Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe IgA Nephropathy Drugs Market Size (2017-2028)
• 7.2 Europe IgA Nephropathy Drugs Market Size by Type
  • 7.2.1 Europe IgA Nephropathy Drugs Market Size by Type (2017-2022)
  • 7.2.2 Europe IgA Nephropathy Drugs Market Size by Type (2023-2028)
  • 7.2.3 Europe IgA Nephropathy Drugs Market Share by Type (2017-2028)
• 7.3 Europe IgA Nephropathy Drugs Market Size by Application
  • 7.3.1 Europe IgA Nephropathy Drugs Market Size by Application (2017-2022)
  • 7.3.2 Europe IgA Nephropathy Drugs Market Size by Application (2023-2028)
  • 7.3.3 Europe IgA Nephropathy Drugs Market Share by Application (2017-2028)
• 7.4 Europe IgA Nephropathy Drugs Market Size by Country
  • 7.4.1 Europe IgA Nephropathy Drugs Market Size by Country (2017-2022)
  • 7.4.2 Europe IgA Nephropathy Drugs Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific IgA Nephropathy Drugs Market Size (2017-2028)
• 8.2 Asia-Pacific IgA Nephropathy Drugs Market Size by Type
  • 8.2.1 Asia-Pacific IgA Nephropathy Drugs Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific IgA Nephropathy Drugs Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific IgA Nephropathy Drugs Market Share by Type (2017-2028)
• 8.3 Asia-Pacific IgA Nephropathy Drugs Market Size by Application
  • 8.3.1 Asia-Pacific IgA Nephropathy Drugs Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific IgA Nephropathy Drugs Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific IgA Nephropathy Drugs Market Share by Application (2017-2028)
• 8.4 Asia-Pacific IgA Nephropathy Drugs Market Size by Region
  • 8.4.1 Asia-Pacific IgA Nephropathy Drugs Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific IgA Nephropathy Drugs Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America IgA Nephropathy Drugs Market Size (2017-2028)
• 9.2 Latin America IgA Nephropathy Drugs Market Size by Type
  • 9.2.1 Latin America IgA Nephropathy Drugs Market Size by Type (2017-2022)
  • 9.2.2 Latin America IgA Nephropathy Drugs Market Size by Type (2023-2028)
  • 9.2.3 Latin America IgA Nephropathy Drugs Market Share by Type (2017-2028)
• 9.3 Latin America IgA Nephropathy Drugs Market Size by Application
  • 9.3.1 Latin America IgA Nephropathy Drugs Market Size by Application (2017-2022)
  • 9.3.2 Latin America IgA Nephropathy Drugs Market Size by Application (2023-2028)
  • 9.3.3 Latin America IgA Nephropathy Drugs Market Share by Application (2017-2028)
• 9.4 Latin America IgA Nephropathy Drugs Market Size by Country
  • 9.4.1 Latin America IgA Nephropathy Drugs Market Size by Country (2017-2022)
  • 9.4.2 Latin America IgA Nephropathy Drugs Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa IgA Nephropathy Drugs Market Size (2017-2028)
• 10.2 Middle East & Africa IgA Nephropathy Drugs Market Size by Type
  • 10.2.1 Middle East & Africa IgA Nephropathy Drugs Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa IgA Nephropathy Drugs Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa IgA Nephropathy Drugs Market Share by Type (2017-2028)
• 10.3 Middle East & Africa IgA Nephropathy Drugs Market Size by Application
  • 10.3.1 Middle East & Africa IgA Nephropathy Drugs Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa IgA Nephropathy Drugs Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa IgA Nephropathy Drugs Market Share by Application (2017-2028)
• 10.4 Middle East & Africa IgA Nephropathy Drugs Market Size by Country
  • 10.4.1 Middle East & Africa IgA Nephropathy Drugs Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa IgA Nephropathy Drugs Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Calliditas Therapeutics
  • 11.1.1 Calliditas Therapeutics Company Details
  • 11.1.2 Calliditas Therapeutics Business Overview
  • 11.1.3 Calliditas Therapeutics IgA Nephropathy Drugs Introduction
  • 11.1.4 Calliditas Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022)
  • 11.1.5 Calliditas Therapeutics Recent Developments
• 11.2 Travere Therapeutics
  • 11.2.1 Travere Therapeutics Company Details
  • 11.2.2 Travere Therapeutics Business Overview
  • 11.2.3 Travere Therapeutics IgA Nephropathy Drugs Introduction
  • 11.2.4 Travere Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022)
  • 11.2.5 Travere Therapeutics Recent Developments
• 11.3 Omeros Corporation
  • 11.3.1 Omeros Corporation Company Details
  • 11.3.2 Omeros Corporation Business Overview
  • 11.3.3 Omeros Corporation IgA Nephropathy Drugs Introduction
  • 11.3.4 Omeros Corporation Revenue in IgA Nephropathy Drugs Business (2017-2022)
  • 11.3.5 Omeros Corporation Recent Developments
• 11.4 Novartis International
  • 11.4.1 Novartis International Company Details
  • 11.4.2 Novartis International Business Overview
  • 11.4.3 Novartis International IgA Nephropathy Drugs Introduction
  • 11.4.4 Novartis International Revenue in IgA Nephropathy Drugs Business (2017-2022)
  • 11.4.5 Novartis International Recent Developments
• 11.5 Chinook Therapeutics
  • 11.5.1 Chinook Therapeutics Company Details
  • 11.5.2 Chinook Therapeutics Business Overview
  • 11.5.3 Chinook Therapeutics IgA Nephropathy Drugs Introduction
  • 11.5.4 Chinook Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022)
  • 11.5.5 Chinook Therapeutics Recent Developments
• 11.6 Vera Therapeutics
  • 11.6.1 Vera Therapeutics Company Details
  • 11.6.2 Vera Therapeutics Business Overview
  • 11.6.3 Vera Therapeutics IgA Nephropathy Drugs Introduction
  • 11.6.4 Vera Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022)
  • 11.6.5 Vera Therapeutics Recent Developments
• 11.7 Otsuka Pharmaceutical
  • 11.7.1 Otsuka Pharmaceutical Company Details
  • 11.7.2 Otsuka Pharmaceutical Business Overview
  • 11.7.3 Otsuka Pharmaceutical IgA Nephropathy Drugs Introduction
  • 11.7.4 Otsuka Pharmaceutical Revenue in IgA Nephropathy Drugs Business (2017-2022)
  • 11.7.5 Otsuka Pharmaceutical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

• Table 1. Global IgA Nephropathy Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Phase I
• Table 3. Key Players of Phase II
• Table 4. Key Players of Phase III
• Table 5. Global IgA Nephropathy Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 6. Global IgA Nephropathy Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 7. Global IgA Nephropathy Drugs Market Size by Region (2017-2022) & (US$ Million)
• Table 8. Global IgA Nephropathy Drugs Market Share by Region (2017-2022)
• Table 9. Global IgA Nephropathy Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 10. Global IgA Nephropathy Drugs Market Share by Region (2023-2028)
• Table 11. IgA Nephropathy Drugs Market Trends
• Table 12. IgA Nephropathy Drugs Market Drivers
• Table 13. IgA Nephropathy Drugs Market Challenges
• Table 14. IgA Nephropathy Drugs Market Restraints
• Table 15. Global IgA Nephropathy Drugs Revenue by Players (2017-2022) & (US$ Million)
• Table 16. Global IgA Nephropathy Drugs Revenue Share by Players (2017-2022)
• Table 17. Global Top IgA Nephropathy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgA Nephropathy Drugs as of 2021)
• Table 18. Ranking of Global Top IgA Nephropathy Drugs Companies by Revenue (US$ Million) in 2021
• Table 19. Global 5 Largest Players Market Share by IgA Nephropathy Drugs Revenue (CR5 and HHI) & (2017-2022)
• Table 20. Key Players Headquarters and Area Served
• Table 21. Key Players IgA Nephropathy Drugs Product Solution and Service
• Table 22. Date of Enter into IgA Nephropathy Drugs Market
• Table 23. Mergers & Acquisitions, Expansion Plans
• Table 24. Global IgA Nephropathy Drugs Market Size by Type (2017-2022) & (US$ Million)
• Table 25. Global IgA Nephropathy Drugs Revenue Market Share by Type (2017-2022)
• Table 26. Global IgA Nephropathy Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 27. Global IgA Nephropathy Drugs Revenue Market Share by Type (2023-2028)
• Table 28. Global IgA Nephropathy Drugs Market Size by Application (2017-2022) & (US$ Million)
• Table 29. Global IgA Nephropathy Drugs Revenue Share by Application (2017-2022)
• Table 30. Global IgA Nephropathy Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 31. Global IgA Nephropathy Drugs Revenue Share by Application (2023-2028)
• Table 32. North America IgA Nephropathy Drugs Market Size by Type (2017-2022) & (US$ Million)
• Table 33. North America IgA Nephropathy Drugs Market Size by Type (2023-2028) & (US$ Million)
• Table 34. North America IgA Nephropathy Drugs Market Size by Application (2017-2022) & (US$ Million)
• Table 35. North America IgA Nephropathy Drugs Market Size by Application (2023-2028) & (US$ Million)
• Table 36. North America IgA Nephropathy Drugs Market Size by Country (2017-2022) & (US$ Million)
• Table 37. North America IgA Nephropathy Drugs Market Size by Country (2023-2028) & (US$ Million)
• Table 38. Europe IgA Nephropathy Drugs Market Size by Type (2017-2022) & (US$ Million)
• Table 39. Europe IgA Nephropathy Drugs Market Size by Type (2023-2028) & (US$ Million)
• Table 40. Europe IgA Nephropathy Drugs Market Size by Application (2017-2022) & (US$ Million)
• Table 41. Europe IgA Nephropathy Drugs Market Size by Application (2023-2028) & (US$ Million)
• Table 42. Europe IgA Nephropathy Drugs Market Size by Country (2017-2022) & (US$ Million)
• Table 43. Europe IgA Nephropathy Drugs Market Size by Country (2023-2028) & (US$ Million)
• Table 44. Asia Pacific IgA Nephropathy Drugs Market Size by Type (2017-2022) & (US$ Million)
• Table 45. Asia Pacific IgA Nephropathy Drugs Market Size by Type (2023-2028) & (US$ Million)
• Table 46. Asia Pacific IgA Nephropathy Drugs Market Size by Application (2017-2022) & (US$ Million)
• Table 47. Asia Pacific IgA Nephropathy Drugs Market Size by Application (2023-2028) & (US$ Million)
• Table 48. Asia Pacific IgA Nephropathy Drugs Market Size by Region (2017-2022) & (US$ Million)
• Table 49. Asia Pacific IgA Nephropathy Drugs Market Size by Region (2023-2028) & (US$ Million)
• Table 50. Latin America IgA Nephropathy Drugs Market Size by Type (2017-2022) & (US$ Million)
• Table 51. Latin America IgA Nephropathy Drugs Market Size by Type (2023-2028) & (US$ Million)
• Table 52. Latin America IgA Nephropathy Drugs Market Size by Application (2017-2022) & (US$ Million)
• Table 53. Latin America IgA Nephropathy Drugs Market Size by Application (2023-2028) & (US$ Million)
• Table 54. Latin America IgA Nephropathy Drugs Market Size by Country (2017-2022) & (US$ Million)
• Table 55. Latin America IgA Nephropathy Drugs Market Size by Country (2023-2028) & (US$ Million)
• Table 56. Middle East and Africa IgA Nephropathy Drugs Market Size by Type (2017-2022) & (US$ Million)
• Table 57. Middle East and Africa IgA Nephropathy Drugs Market Size by Type (2023-2028) & (US$ Million)
• Table 58. Middle East and Africa IgA Nephropathy Drugs Market Size by Application (2017-2022) & (US$ Million)
• Table 59. Middle East and Africa IgA Nephropathy Drugs Market Size by Application (2023-2028) & (US$ Million)
• Table 60. Middle East and Africa IgA Nephropathy Drugs Market Size by Country (2017-2022) & (US$ Million)
• Table 61. Middle East and Africa IgA Nephropathy Drugs Market Size by Country (2023-2028) & (US$ Million)
• Table 62. Calliditas Therapeutics Company Details
• Table 63. Calliditas Therapeutics Business Overview
• Table 64. Calliditas Therapeutics IgA Nephropathy Drugs Product
• Table 65. Calliditas Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022) & (US$ Million)
• Table 66. Calliditas Therapeutics Recent Developments
• Table 67. Travere Therapeutics Company Details
• Table 68. Travere Therapeutics Business Overview
• Table 69. Travere Therapeutics IgA Nephropathy Drugs Product
• Table 70. Travere Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022) & (US$ Million)
• Table 71. Travere Therapeutics Recent Developments
• Table 72. Omeros Corporation Company Details
• Table 73. Omeros Corporation Business Overview
• Table 74. Omeros Corporation IgA Nephropathy Drugs Product
• Table 75. Omeros Corporation Revenue in IgA Nephropathy Drugs Business (2017-2022) & (US$ Million)
• Table 76. Omeros Corporation Recent Developments
• Table 77. Novartis International Company Details
• Table 78. Novartis International Business Overview
• Table 79. Novartis International IgA Nephropathy Drugs Product
• Table 80. Novartis International Revenue in IgA Nephropathy Drugs Business (2017-2022) & (US$ Million)
• Table 81. Novartis International Recent Developments
• Table 82. Chinook Therapeutics Company Details
• Table 83. Chinook Therapeutics Business Overview
• Table 84. Chinook Therapeutics IgA Nephropathy Drugs Product
• Table 85. Chinook Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022) & (US$ Million)
• Table 86. Chinook Therapeutics Recent Developments
• Table 87. Vera Therapeutics Company Details
• Table 88. Vera Therapeutics Business Overview
• Table 89. Vera Therapeutics IgA Nephropathy Drugs Product
• Table 90. Vera Therapeutics Revenue in IgA Nephropathy Drugs Business (2017-2022) & (US$ Million)
• Table 91. Vera Therapeutics Recent Developments
• Table 92. Otsuka Pharmaceutical Company Details
• Table 93. Otsuka Pharmaceutical Business Overview
• Table 94. Otsuka Pharmaceutical IgA Nephropathy Drugs Product
• Table 95. Otsuka Pharmaceutical Revenue in IgA Nephropathy Drugs Business (2017-2022) & (US$ Million)
• Table 96. Otsuka Pharmaceutical Recent Developments
• Table 97. Research Programs/Design for This Report
• Table 98. Key Data Information from Secondary Sources
• Table 99. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global IgA Nephropathy Drugs Market Share by Type: 2021 VS 2028
• Figure 2. Phase I Features
• Figure 3. Phase II Features
• Figure 4. Phase III Features
• Figure 5. Global IgA Nephropathy Drugs Market Share by Application: 2021 VS 2028
• Figure 6. Clinical Treatment Case Studies
• Figure 7. Drug Experiment Case Studies
• Figure 8. IgA Nephropathy Drugs Report Years Considered
• Figure 9. Global IgA Nephropathy Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 10. Global IgA Nephropathy Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 11. Global IgA Nephropathy Drugs Market Share by Region: 2021 VS 2028
• Figure 12. Global IgA Nephropathy Drugs Market Share by Players in 2021
• Figure 13. Global Top IgA Nephropathy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgA Nephropathy Drugs as of 2021)
• Figure 14. The Top 10 and 5 Players Market Share by IgA Nephropathy Drugs Revenue in 2021
• Figure 15. North America IgA Nephropathy Drugs Market Size YoY (2017-2028) & (US$ Million)
• Figure 16. North America IgA Nephropathy Drugs Market Size Market Share by Type (2017-2028)
• Figure 17. North America IgA Nephropathy Drugs Market Size Market Share by Application (2017-2028)
• Figure 18. North America IgA Nephropathy Drugs Market Size Share by Country (2017-2028)
• Figure 19. United States IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 20. Canada IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Europe IgA Nephropathy Drugs Market Size YoY (2017-2028) & (US$ Million)
• Figure 22. Europe IgA Nephropathy Drugs Market Size Market Share by Type (2017-2028)
• Figure 23. Europe IgA Nephropathy Drugs Market Size Market Share by Application (2017-2028)
• Figure 24. Europe IgA Nephropathy Drugs Market Size Share by Country (2017-2028)
• Figure 25. Germany IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 26. France IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. U.K. IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. Italy IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Russia IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Nordic Countries IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Asia-Pacific IgA Nephropathy Drugs Market Size YoY (2017-2028) & (US$ Million)
• Figure 32. Asia Pacific IgA Nephropathy Drugs Market Size Market Share by Type (2017-2028)
• Figure 33. Asia Pacific IgA Nephropathy Drugs Market Size Market Share by Application (2017-2028)
• Figure 34. Asia Pacific IgA Nephropathy Drugs Market Size Share by Region (2017-2028)
• Figure 35. China IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. Japan IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. South Korea IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. Southeast Asia IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. India IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. Australia IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 41. Latin America IgA Nephropathy Drugs Market Size YoY (2017-2028) & (US$ Million)
• Figure 42. Latin America IgA Nephropathy Drugs Market Size Market Share by Type (2017-2028)
• Figure 43. Latin America IgA Nephropathy Drugs Market Size Market Share by Application (2017-2028)
• Figure 44. Latin America IgA Nephropathy Drugs Market Size Share by Country (2017-2028)
• Figure 45. Mexico IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 46. Brazil IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Middle East & Africa IgA Nephropathy Drugs Market Size YoY (2017-2028) & (US$ Million)
• Figure 48. Middle East and Africa IgA Nephropathy Drugs Market Size Market Share by Type (2017-2028)
• Figure 49. Middle East and Africa IgA Nephropathy Drugs Market Size Market Share by Application (2017-2028)
• Figure 50. Middle East and Africa IgA Nephropathy Drugs Market Size Share by Country (2017-2028)
• Figure 51. Turkey IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 52. Saudi Arabia IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. UAE IgA Nephropathy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. Calliditas Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2017-2022)
• Figure 55. Travere Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2017-2022)
• Figure 56. Omeros Corporation Revenue Growth Rate in IgA Nephropathy Drugs Business (2017-2022)
• Figure 57. Novartis International Revenue Growth Rate in IgA Nephropathy Drugs Business (2017-2022)
• Figure 58. Chinook Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2017-2022)
• Figure 59. Vera Therapeutics Revenue Growth Rate in IgA Nephropathy Drugs Business (2017-2022)
• Figure 60. Otsuka Pharmaceutical Revenue Growth Rate in IgA Nephropathy Drugs Business (2017-2022)
• Figure 61. Bottom-up and Top-down Approaches for This Report
• Figure 62. Data Triangulation
• Figure 63. Key Executives Interviewed